RESCAP in severe burn wound trial

Alloksys's RESCAP platform therapeutic compound will be applied in patients that suffer from severe burn trauma. RESCAP administration is expected to significantly attenuate the overall ischemic clinical condition of these…

Continue Reading RESCAP in severe burn wound trial

January 2020 APPIRED III

APPIRED III study is getting well on its way with 9 centres started with including patients. These centres are Singapore NUH, CZE Eindhoven, Jessa, Hasselt, UniMed Wien Vienna, Almazov Heart…

Continue Reading January 2020 APPIRED III

APPIRED III started recruitment in Asia at NUHCS, Singapore

Following the start of patient inclusion in Europe, the first Asian center participating international study APPIRED lll has started patient recruitment. The National University Heart Centre, Singapore (NUHCS) is the…

Continue Reading APPIRED III started recruitment in Asia at NUHCS, Singapore